Cambridge Innovation Capital received a positive IDMC recommendation for Complement Therapeutics.
Published
Signal category
Capital & Finance
Quote
“positive IDMC recommendation”
— Cambridge Innovation Capital team
Company
Cambridge Innovation Capital
A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies.
- Industry
- Venture Capital and Private Equity Principals
- Location
- Cambridge, GB
- Company size
- 36 employees
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Founded 2013